2023 Update: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

Marcello Casaccia Bertoluci, Wellington S Silva Júnior, Fernando Valente, Levimar Rocha Araujo, Ruy Lyra, João Jácome de Castro, João Filipe Raposo, Paulo Augusto Carvalho Miranda, Cesar Luiz Boguszewski, Alexandre Hohl, Rui Duarte, João Eduardo Nunes Salles, José Silva-Nunes, Jorge Dores, Miguel Melo, João Roberto de Sá, João Sérgio Neves, Rodrigo Oliveira Moreira, Marcus Vinícius Bolívar Malachias, Rodrigo Nunes LamounierDomingos Augusto Malerbi, Luis Eduardo Calliari, Luis Miguel Cardoso, Maria Raquel Carvalho, Hélder José Ferreira, Rita Nortadas, Fábio Rogério Trujilho, Cristiane Bauermann Leitão, José Augusto Rodrigues Simões, Mónica Isabel Natal Dos Reis, Pedro Melo, Mafalda Marcelino, Davide Carvalho

Research output: Contribution to journal › Review article › peer-review

5 Citations (Scopus)
36 Downloads (Pure)

Fingerprint

Dive into the research topics of '2023 Update: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences